Effect of carbamazepine on psychomotor performance in näive subjects. 1986

G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie

The effect of a single dose of carbamazepine (CBZ), 10 mg kg-1, on a battery of simple psychomotor tests was investigated in 12 healthy subjects (6 male, 6 female) in a balanced randomised double blind placebo controlled cross-over study. Psychomotor testing and blood sampling for total and free plasma CBZ, and CBZ 10, 11 epoxide concentration were performed at 10, 12, 14, 16, 18 and 34 h after oral dosing (23.00 h the previous evening). CBZ impaired i) critical flicker fusion threshold frequency at all time points up to 18 h (p less than 0.005); ii) total choice reaction time at 10 h (p less than 0.005) and 18 h (p less than 0.008); iii) card sorting at 14 h (p less than 0.001). No significant effect on finger tapping was noted. Subjects adjudged themselves more sedated on CBZ as compared to placebo at 12, 14 and 16 h (p less than 0.008). Plasma total and free CBZ concentrations (mean +/- SD) peaked at 10 h (8.8 +/- 0.2 mg 1-1) and 16 h (1.88 +/- 0.3 mg 1-1) after dosing respectively. CBZ 10, 11 epoxide values were all less than 10% of total CBZ concentrations and, therefore, were unlikely to contribute to the pharmacodynamic effect. Total choice reaction time was significantly more impaired in females (p less than 0.05) but no sex difference occurred with the other tests or CBZ concentrations at any time point. No significant correlations were found between individual total or free CBZ concentrations and corresponding test performances at each time point.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D005260 Female Females
D005425 Flicker Fusion The point or frequency at which all flicker of an intermittent light stimulus disappears. Flicker Fusions,Fusion, Flicker,Fusions, Flicker
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
January 1995, European journal of clinical pharmacology,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
January 1988, British journal of clinical pharmacology,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
June 1991, The Journal of the Association of Physicians of India,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
January 1978, Acta anaesthesiologica Scandinavica,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
November 1988, British journal of clinical pharmacology,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
November 1993, British journal of clinical pharmacology,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
February 1980, Aviation, space, and environmental medicine,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
February 1998, Anaesthesia,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
June 1976, Psychopharmacology,
G J MacPhee, and C Goldie, and D Roulston, and L Potter, and E Agnew, and J Laidlaw, and M J Brodie
May 2001, Parasitology,
Copied contents to your clipboard!